1. Clinician Perspectives on Current Issues in Lung Cancer Drug Development 
Saiama N. Waqar, M.B.B.S., MSCI, Philip D. Bonomi, MD, Ramaswamy Govindan, MD, Fred R. Hirsch, MD, PhD, Gregory J. Riely, MD, Vassiliki Papadimitrakopoulou, MD, Dickran Kazandjian, MD, Sean Khozin, MD, Erin Larkins, MD, Dane J. Dickson, MD, Shakun Malik, MD, Leora Horn, MD, Andrea Ferris, MBA, Alice T. Shaw, MD, PhD, Pasi A. Jänne, MD, PhD, Tony S.K. Mok, MD, Roy Herbst, MD, PhD, Patricia Keegan, MD, Richard Pazdur, MD, Gideon M. Blumenthal, MD 
Journal of Thoracic Oncology 
Volume 11, Issue 9, Pages (September 2016)
DOI: /j.jtho
Copyright © Terms and Conditions

2. Figure 1
U.S. Food and Drug Administration non–small cell lung cancer therapeutic drug approvals by year.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © Terms and Conditions